MEDXTRACTOR CORP. ANNOUNCES LISTING ON THE CSE

P R E S S   R E L E A S E

MEDXTRACTOR CORP. ANNOUNCES LISTING ON THE CSE

For Immediate Release

Calgary, Alberta – October 23, 2019. MedXtractor Corp. (CSE: MXT) (“Medx” or the “Corporation”) is pleased to announce it has received a receipt from the Alberta Securities Commission for the filing of its final non-offering long form prospectus on October 9, 2019. A copy of the prospectus is available under the Corporation’s profile on SEDAR (www.sedar.com). All required listing documents have been filed with the Canadian Securities Exchange (“CSE”) and the common shares of the Corporation are expected to commence trading on the CSE under the trading symbol “MXT” on October 24, 2019.  

On October 9, 2019, the Corporation granted an aggregate of 375,000 stock options to a director of the Corporation exercisable on or before October 9, 2024 at an exercise price of $0.08 per common share.

The following individuals comprise Medx’s board of directors and management team: James M. Durward (President, CEO, Corporate Secretary and Director), G. Steven Price (Director), Dusan Kuzma (Director), Dwayne Vinck (Chief Financial Officer) and Neil A. Runions (Director).

James M. Durward, the Corporation’s President and CEO, states “Medxtractor is experiencing significant sales growth and, unlike most cannabis-related operations, is currently generating positive cash flow from operations. When combined with a market capitalization far below its peers, Medxtractor offers significant potential upside for the cannabis investor.”

In addition, the Corporation announces the filing of its unaudited interim condensed financial statements and management discussion and analysis for the six month period ended August 31, 2019. The filings are available for review on SEDAR (www.sedar.com).

ABOUT MEDXTRACTOR CORP.:

The Corporation is a Calgary-based company that manufactures proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the patents on its CO2-based extraction process.

FOR FURTHER INFORMATION, PLEASE CONTACT:

MEDXTRACTOR CORP.

James M. Durward, President and CEO                                                                                                          

Telephone: (403) 689-3901                                                                                                                              

Email:   [email protected]

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States.  The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.